Flobak Å, Skånland SS, Hovig E, Taskén K, Russnes HG (2022)
Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models
Trends Pharmacol Sci (in press)
DOI 10.1016/j.tips.2022.08.009, PubMed 36163057

Holm MB, Verbeke CS (2022)
Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal Adenocarcinoma
Curr Oncol, 29 (9), 6551-6563
DOI 10.3390/curroncol29090515, PubMed 36135084

Park JR, Villablanca JG, Hero B, Kushner BH, Wheatley K, Beiske KH, Ladenstein RL, Baruchel S, Macy ME, Moreno L, Seibel NL, Pearson AD, Matthay KK, Valteau-Couanet D (2022)
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting
Cancer (in press)
DOI 10.1002/cncr.34445, PubMed 36101004